PepGen (PEPG) announced positive clinical data from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose study in patients with myotonic dystrophy type 1. These latest ...

Twenty years ago, two economists responded to a slew of help-wanted ads in Boston and Chicago newspapers using a set of fictitious names to test for racial bias in the job market. The watershed study ...